You searched for "surgeons"
From the editor / ENT in this issue... CEORL-HNS Brussels 2019 (JanFeb19)
Declan Costello, MA, MBBS, FRCS(ORL-HNS),Editor, ENT & Audiology News; Consultant Ear, Nose and Throat Surgeon, Wexham Park Hospital, Slough, Berkshire, UK Email: d.costello@nhs.net Welcome As we turn the corner from 2018 into 2019, it is interesting to reflect that we...From the editor March/April 2023
Declan Costello, MA, MBBS, FRCS(ORL-HNS),Consultant Ear, Nose and Throat Surgeon, Wexham Park Hospital, Slough, Berkshire, UK. E: d.costello@nhs.netTw: @Voicedoctor_uk The world of audiology and ENT will already know of the tragic death of Professor David Baguley in June 2022 at...From the editor Jul/Aug 2024
Declan Costello, MA, MBBS, FRCS(ORL-HNS),Consultant Ear, Nose and Throat Surgeon, Wexham Park Hospital, Slough, Berkshire, UK. E: d.costello@nhs.netTW / X: @Voicedoctor_uk Congress season is well underway around the world – with all that’s going on, it’s hard to keep track...New RSM presidents preview the year ahead
Professor Patrick Axon, President of the UK’s Royal Society of Medicine Otology Section and Michelle Wyatt, incoming President of the section of Laryngology and Rhinology, look forward to the year ahead.Cochlear implant care for deaf children in Côte d’Ivoire
Deafness is a global public health problem. More than 1.5 billion people (nearly 20% of the global population) live with hearing loss, and 430 million of them have disabling hearing loss, including 34 million children. In sub-Saharan Africa, nearly eight...Cochlear implant referral: how can we do better?
Considerable progress has been made over the last few years in improving access to cochlear implantation (CI) in the UK for children and adults with severe to profound deafness. But we are still not treating children early enough, and we...The changing spectrum of cancer of the oropharynx: dilemmas and future directions
The association of HPV in oropharyngeal cancer has identified a ‘new disease’, with its unique biologic behaviour, and challenges for clinicians in selecting therapeutic combinations offering maximum efficacy and minimum morbidity or long-term sequela currently under study in clinical trials....
